Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

Hypoxia

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Hyperpnea and Hyperventilation

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development of an innovative partnership between a health-system department of pharmacy and external community pharmacies.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2022

Same author

Workplace strategies to reduce pharmacy leadership burnout.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2019

Same author

Synthesis of Selective Estrogen Receptor Degrader GDC-0810 via Stereocontrolled Assembly of a Tetrasubstituted All-Carbon Olefin.

The Journal of organic chemistry·2018

Same author

Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.

Journal of oncology practice·2018

Same author

Practical strategies when using a stable isotope labeled microtracer for absolute bioavailability assessment: A case study of a high oral dose clinical candidate GDC-0810.

Journal of pharmaceutical and biomedical analysis·2018

Same author

Synthesis of a Selective Estrogen Receptor Degrader via a Stereospecific Elimination Approach.

Organic letters·2018

Same journal

REVITALIZATION IN THE UPPER CUMBERLAND.

Tennessee medicine : journal of the Tennessee Medical Association·2018

Same journal

OUR “COTTAGE INDUSTRY”: ALAS, I KNEW IT WELL!

Tennessee medicine : journal of the Tennessee Medical Association·2018

Same journal

DRUG-RELATED DEATHS: THE MEDICAL EXAMINER PERSPECTIVE.

Tennessee medicine : journal of the Tennessee Medical Association·2018

Same journal

PAIN RELIEF DOESN’T ALWAYS COME IN A PILL.

Tennessee medicine : journal of the Tennessee Medical Association·2018

Same journal

THE GOOD NEWS/ BAD NEWS ABOUT TENNESSEE’S OPIOID EPIDEMIC.

Tennessee medicine : journal of the Tennessee Medical Association·2018

Same journal

NO EASY FIX.

Tennessee medicine : journal of the Tennessee Medical Association·2018

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

New medical therapy: hyperbarics.

¹Hyperbaric Medicine Department at St Mary's Hospital, Knoxville, USA. joseph.s.savage@nasa.gov

Tennessee Medicine : Journal of the Tennessee Medical Association

|April 9, 2010

Summary

This summary is machine-generated.

Hyperbaric medicine, using increased oxygen, treats various conditions. This review covers its mechanisms, common uses, access, concerns, and effectiveness.

Related Experiment Videos

Last Updated: Jun 14, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Area of Science:

Hyperbaric medicine
Oxygen therapy

Background:

Review of hyperbaric medicine essentials.
Covers mechanism of action, indications, access, concerns, and effectiveness.

Observation:

Details the six most common indications for hyperbaric oxygen therapy.
Explains typical treatment concerns and methods of accessing care.

Findings:

Summarizes the effectiveness of hyperbaric medicine across various applications.
Provides a foundational understanding of hyperbaric oxygen therapy.

Implications:

Informs patients and healthcare providers about hyperbaric medicine.
Highlights the importance of understanding treatment protocols and outcomes.